Search
for

    Sort by

    Research 631–660 of 1000+

    1. Price discrimination across indications in the pharmaceutical industry: The case of finasteride OpenMETU (Middle East Technical University) · 2006
    2. Why would men use finasteride in 2005? Current Prostate Reports · 2005
    3. Tratamientos fitoterapeúticos para la hipertrofia benigna de próstata: serenoa repens Metas de Enfermería · 2005
    4. Le financement du cycle de l'eau en région flamande Psychoneuroendocrinology · 2005
    5. Successes and failures of evidence based urology 2005
    6. The effective course of finasteride pretreatment in decreasing blood loss associated with TURP Journal of Clinical Urology · 2005
    7. 走进非洲传统医药学宝库IV：与良性前列腺肥大、农民利益、品种灭绝、国际法规和巨大经济效益休戚相关的非洲李 国外医药：植物药分册 · 2005
    8. Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer SUNScholar (Stellenbosch University) · 2004
    9. Editorial comment 1 Urology · 2004
    10. La combinación de finasteride y doxazosina fue más efectiva que la monoterapia en la hiperplasia prostática benigna Evidencia actualizacion en la práctica ambulatoria · 2004
    11. Finasteride en mammacarcinoom bij mannen Medisch-Farmaceutische Mededelingen · 2004
    12. Long-Term Effectiveness of Finasteride for BPH Journal watch · 2004
    13. Finasteride en de preventie van prostaatcarcinoom Medisch-Farmaceutische Mededelingen · 2004
    14. TACRINE 2004
    15. Latent hazard in PC and BPH patients referred to antiandrogens:PC aggressiveness and NE differentiation Anticancer Research · 2004
    16. Analysis of Cost-effectiveness of 4 Kinds of Projects for Drug Therapy in the Treatment of BPH Zhongguo yiyuan yongyao pingjia yu fenxi · 2004
    17. Expression and Activity Assay of Human Steroid 5 Alpha-Reductase Type II in CHO Cells Pharmaceutical biotechnology · 2004
    18. Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo European Urology Supplements · 2003
    19. 40gm 미만의 전립선비대증에서 α-차단제와 Finasteride 병합요법의 유용성 2003
    20. The preparation and stability of the finasteride tablets Chinese Journal of Hospital Pharmacy · 2002
    21. Influencia del tratamiento con alfa bloqueantes e inhibidores de la 5 alfa reductasa en los hallazgos morfológicos e inmunohistoquímicos de la hiperplasia benigna de próstata Dialnet (Universidad de la Rioja) · 2002
    22. 保法止（非那雄胺）治疗雄激素性脱发 皮肤病与性病 · 2001
    23. 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione Acta Crystallographica Section C-crystal Structure Communications · 1998
    24. Diagnosis Of Occult Asthma By Methacholine Bronchoprovocation Test Lung India · 1986
    25. US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know? European urology open science · 2023
    26. PD02-05 SRD5A2 EXPRESSION IS A PREDICTOR OF RESPONSE TO FINASTERIDE IN THE MTOPS TRIAL The Journal of Urology · 2023
    27. Comorbidities in Androgenetic Alopecia: A Comprehensive Review Dermatology and therapy · 2022
    28. SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients Frontiers in Immunology · 2022
    29. Synthesis, Characterization and Evaluation of 5α, 6β-Dihalo Androsterone Derivatives as 5α-Reductase Inhibitors Current Enzyme Inhibition · 2022
    30. 017 Pharmacovigilance Analysis of Reports of Sexual Dysfunction Associated with Finasteride Use: Implications for the Post-Finasteride Syndrome The Journal of Sexual Medicine · 2022